Abiopharma

🔍 RANGER MICHAEL W (Director)

Company: CONSOLIDATED EDISON INC (ED)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 431 shares of Common Stock at $113.18 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 99,017.13 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents Deferred Stock Units ("DSUs") acquired in lieu of cash for the quarterly board retainer fee at the election of the filer, pursuant to the terms of the Consolidated Edison, Inc. (the "Company") Long Term Incentive Plan (the "Plan"). Each DSU represents one share of the Company's Common Stock.
• F2: Includes 764.245 DSUs acquired on March 16, 2026, pursuant to the Plan's dividend reinvestment provision.